Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $223.87 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.14 | 3 | $0 (2023) |
| ABBVIE INC. | $53.59 | 2 | $0 (2023) |
| Exact Sciences Corporation | $28.30 | 1 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $24.05 | 1 | $0 (2018) |
| Intuitive Surgical, Inc. | $21.47 | 1 | $0 (2022) |
| Dexcom, Inc. | $19.69 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $19.63 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.69 | 1 | Dexcom, Inc. ($19.69) |
| 2023 | $93.31 | 4 | Exact Sciences Corporation ($28.30) |
| 2022 | $86.82 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.52) |
| 2018 | $24.05 | 1 | PORTOLA PHARMACEUTICALS, INC. ($24.05) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Endocrinology | ||||||
| 10/09/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Oncology | ||||||
| 08/03/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: DIABETES | ||||||
| 03/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: INSOMNIA | ||||||
| 10/18/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: SURGERY | ||||||
| 09/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: DIABETES | ||||||
| 07/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: DIABETES | ||||||
| 04/04/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,489 | 1,748 | $458,139 | $151,906 |
| 2022 | 14 | 892 | 1,063 | $269,657 | $110,662 |
| 2021 | 6 | 601 | 789 | $350,613 | $73,778 |
| 2020 | 12 | 1,121 | 1,625 | $633,918 | $118,543 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 370 | 561 | $171,105 | $46,580 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 370 | 370 | $115,440 | $39,053 | 33.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 75 | 75 | $28,575 | $21,105 | 73.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 245 | 293 | $61,530 | $17,909 | 29.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 67 | 67 | $8,492 | $5,079 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 46 | $18,676 | $4,550 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $14,752 | $3,969 | 26.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 74 | 74 | $5,180 | $2,685 | 51.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 68 | $4,760 | $2,468 | 51.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $6,076 | $2,080 | 34.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 15 | 15 | $5,903 | $1,927 | 32.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 19 | $3,800 | $957.60 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,312 | $815.25 | 18.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 16 | 16 | $1,552 | $804.48 | 51.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 15 | 15 | $1,800 | $725.70 | 40.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,729 | $624.34 | 36.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 39 | $4,134 | $513.93 | 12.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 17 | $323.00 | $57.97 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 244 | 378 | $111,132 | $42,608 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 119 | 119 | $35,819 | $18,232 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 170 | $34,340 | $13,759 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 53 | $20,776 | $8,664 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $20,470 | $6,155 | 30.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $6,256 | $4,727 | 75.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 63 | 63 | $7,702 | $4,426 | 57.5% |
About Dr. Aimee Keyashian, MD
Dr. Aimee Keyashian, MD is a Internal Medicine healthcare provider based in Lafayette, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2013. The National Provider Identifier (NPI) number assigned to this provider is 1578806329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aimee Keyashian, MD has received a total of $223.87 in payments from pharmaceutical and medical device companies, with $19.69 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($223.87).
As a Medicare-enrolled provider, Keyashian has provided services to 4,103 Medicare beneficiaries, totaling 5,225 services with total Medicare billing of $454,890. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lafayette, CA
- Active Since 03/30/2013
- Last Updated 03/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578806329
Products in Payments
- JARDIANCE (Drug) $57.14
- UBRELVY (Drug) $53.59
- Cologuard Collection Kit (Device) $28.30
- BEVYXXA (Drug) $24.05
- Da Vinci Surgical System (Device) $21.47
- Dexcom G6 Transmitter (Medical Supply) $19.69
- QUVIVIQ (Drug) $19.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Hector Robles, Md, MD
Internal Medicine — Payments: $23,742
Dr. Robert Russell, Md, MD
Internal Medicine — Payments: $18,283
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501